An official website of the United States government
Home
Name
Ziextenzo
Alternate Names
pegfilgrastim-bmez
Abbreviations
None
Category
Ancillary Agent
Subcategory
bio-similar
NSC Number
None
Primary Site
None
Histology
None
Remarks
11/5/209
The FDA approved Ziextenzo (pegfilgrastim-bmez), a biosimilar to U.S.-licensed Neulasta (pegfilgrastim).
The FDA approved Ziextenzo (pegfilgrastim-bmez), a biosimilar to U.S.-licensed Neulasta (pegfilgrastim).
Coding
This drug should NOT be coded
